Amunix is an immuno-oncology company leveraging our proprietary, clinically validated Pro-XTEN technology platform to discover and develop transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer. We aim to expand the therapeutic index of TCEs and cytokines, which have demonstrated anti-tumor clinical activity, but have not realized their potential due to dose-limiting on-target, off-tumor toxicity. We address this challenge by using our universal, protease-releasable masking technology (Pro-XTEN), to create next generation, conditionally active TCEs (XPATs®) and cytokines (XPACs), that are preferentially activated in tumors as compared to healthy tissues. Experience and culture matter. At Amunix, we challenge ourselves and our colleagues, and bring a critical eye and rigor to everything we do. Biology is complex and hard to predict, but with deep experience, diversity of thinking, and scientific rigor, we believe we maximize our chance of making a real difference for cancer patients.
View Top Employees from Amunix PharmaceuticalsWebsite | http://www.amunix.com |
Revenue | $7 million |
Funding | $190 million |
Employees | 81 (81 on RocketReach) |
Founded | 2006 |
Address | 2 Tower Place, Suite 1100, South San Francisco, California 94080, US |
Phone | (650) 428-1800 |
Industry | Pharmaceuticals, Biotechnology Research, Biotechnology, Drug Discovery, Healthcare, Science and Engineering, Developer Platform, Software, Therapeutics, Health Care |
Web Rank | 9 Million |
Keywords | Amunix, Amunix Operating, Inc., Angie You Amunix, Amunix.Com, Volker Schellenberger Amunix.Com |
Competitors | Axsome Therapeutics, Inc., Neuraltus Pharmaceuticals, ONL Therapeutics, Orphazyme A/S, Relmada Therapeutics, Inc |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Amunix Pharmaceuticals employee's phone or email?
The Amunix Pharmaceuticals annual revenue was $7 million in 2023.
81 people are employed at Amunix Pharmaceuticals.
Amunix Pharmaceuticals is based in South San Francisco, California.
The NAICS codes for Amunix Pharmaceuticals are [541, 54, 3254, 325, 32541, 32].
The SIC codes for Amunix Pharmaceuticals are [283, 28].